MeSH D015479 - myelomonocytic leukemia acute
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Pfizer | Gemtuzumab ozogamicin | Mylotarg | 2018-04-19 | |||
| Wyeth | Gemtuzumab ozogamicin | Mylotarg | 2017-09-01 |
Clinical Trials
Historical Success Rate
Phase 1
71%24/34
Phase 2
35%17/49
Phase 3
3%1/33
Approved: 1Overall Success rate: 1%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use